Related Experiment Video
Updated: Jan 10, 2026

Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
Published on: May 24, 2018
Distinct body fat distribution and its association with metabolic syndrome in Tibetan population
Lin Yuan1,2, Haijing Wang1,2, Qingxia Huang3
1Department of Public Health, Qinghai University Medical College, Xining, Qinghai, 810008, China.
Objective:
To characterize the specific pattern of body fat distribution and its association with metabolic syndrome (MetS) among Tibetan adults, an understudied population with distinct high-altitude adaptations, and to identify potential mediating biomarkers in serum lipoprotein profiles.
Methods:
A total of 1480 participants from the Tibetan cohort and the NHANES were included. Principal component analysis and Mantel tests were employed to identify Tibetan-specific body fat indicators. Linear models assessed associations with metabolic syndrome (MetS), and mediation analyses evaluated the indirect effects of serum lipoproteins.
Results:
Tibetans showed distinct trunk and total fat mass compared to other ethnic/racial groups. Trunk fat percentage was identified as a risk factor for MetS (OR = 1.59, 95% CI: 1.27 ~ 1.91, p = 0.004). The triglycerides to total lipids ratio in low density lipoprotein 3 (L3TGP) and triglycerides to high density lipoprotein cholesterol ratio (TGHCR) exhibited significant mediating effect between trunk fat percentage and MetS (L3TGP:β = 1.7 × 10- 4g, 95% CI: 4 × 10- 5~3.6 × 10- 4, p<0.001;TGHCR: β = 1.8 × 10- 4g, 95% CI: 4 × 10- 5~4.6 × 10- 4, p<0.001).
Conclusions:
This study revealed novel evidence for distinct fat distribution in Tibetans, linked to elevated MetS risk. L3TGp and TGHCR were identified as key lipoprotein mediators, supporting the need for environmental- and ethnicity-specific indicators in metabolic risk assessment.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Obesity
Hypodermis
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Drug Dosing: Obese Patients

